期刊文献+

纳米材料药物传输载体在治疗眼病中的应用 被引量:2

Applications of nanomaterial-based drug delivery carriers in treating eye diseases
下载PDF
导出
摘要 由于眼表面和眼内结构的解剖、生理屏障作用,常规眼部制剂一般无法到达特定位置发挥作用。纳米材料由于尺寸小、易制备、可降解、靶向性强以及对生物组织刺激性小等特点,不同类型的纳米材料在运载不同化学特性药物方面优势明显。目前,纳米材料作为药物传输载体在眼部给药方面应用越来越多,并被用于各种类型眼部疾病的治疗,显示出良好的应用前景。本文就纳米材料作为药物传输载体在眼科疾病治疗方面的应用作一综述。 In view of the anatomical and physiological barrier of the ocular surface and the intraocular structure, the conventional ophthalmic agents cannot efficiently reach the lesion site. Currently, the different types of nanomaterials possess great advantages in delivering drugs due to their characteristics of small size, easy preparation, degradability, strong targeting and less irritation to biological tissue. As drug delivery carriers, nanomaterials have been widely used in ocular drug delivery so as to treat different types of eye diseases. In this paper, the applications of nanomaterials as drug delivery carriers in treating eye diseases are briefly reviewed.
作者 孙园园 郭大东 李少玉 陈美清 刘滨 毕宏生 Yuan-Yuan Sun Da-Dong Guo Shao-Yu Li Mei-Qing Chen Bin LiuI Hong-Sheng Bi(The Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong Province, China Eye Institute of Shandong University of Traditional Chinese Medicine, Jinan 250002, Shandong Province, China)
出处 《国际眼科杂志》 CAS 2017年第9期1671-1673,共3页 International Eye Science
基金 国家自然科学基金(No.81373826) 山东医药卫生科技发展计划(No.2013WS0251)~~
关键词 纳米材料 药物传输载体 眼病 nanomaterials drug delivery carrier eye diseases
  • 相关文献

参考文献3

二级参考文献28

  • 1郭未艾,王晓黎,吴文捷,张振平.后发性白内障相关因素的临床研究[J].眼视光学杂志,2005,7(2):92-96. 被引量:7
  • 2朱蓉嵘,管怀进,吴坚,胡楠.晶状体囊抛光及透明质酸酶预防囊的浑浊[J].眼外伤职业眼病杂志,2005,27(9):657-659. 被引量:3
  • 3王铮,夏群,刘小伟,崔宝华.人工晶状体眼晶状体后囊膜混浊对视功能的影响[J].国际眼科杂志,2006,6(2):377-380. 被引量:13
  • 4张俊鸽,李平华.后发性白内障预防的研究进展[J].眼科新进展,2007,27(1):69-71. 被引量:5
  • 5Kappelhof JP,Vrenson GF.The pathology of after-cataract.A mini-review[J].Acta Ophthalmol Suppl,1992,205:13-24.
  • 6Spalton DJ.Posterior capsule opacification after cataract surger-y[J].Eye(Lond),1999,13(Pt3b):489-492.
  • 7Meacock WR,Spalton DJ,Standford MR.Role of cytokines in the pathogenesis of posterior capsule opacification[J].Br J Ophthalm ol,2000,84(3):332-336.
  • 8Peng Q,Vesessook N,Apple DJ,Pandey SK,Werner L,Escobar-Gomez M,et al.Surgical prevention of posterior capsule opacifi-cation.Part3:intraocular lens optic harrier effect as a second line of defense[J].J Cataract Refract Surg,2000,26(9):198-213.
  • 9Apple DJ.Influence of intraocular lens material and design on postoperative intracapsular cellular reactivity[J].Trans Am Ophthalm ol Soc,2000,98:257-283.
  • 10Bras ID,Colitz CM,Saville WJ,Gemensky-Metzler AJ,Wilkie DA.Posterior capsule opacification in diabetic and non-diabetic canine patients follow ing cataract surgery[J].Vet Ophthalmol,2006,9(5):317-327.

共引文献18

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部